Cancer de la prostate à l’ère de la médecine de précision : un nouvel horizon [Prostate cancer in the era of precision medicine: a new horizon]
Details
Request a copy Under indefinite embargo.UNIL restricted access
State: Public
Version: author
License: Not specified
Serval ID
serval:BIB_1F5EA2E82D9D
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Cancer de la prostate à l’ère de la médecine de précision : un nouvel horizon [Prostate cancer in the era of precision medicine: a new horizon]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
17/05/2023
Peer-reviewed
Oui
Volume
19
Number
827
Pages
950-956
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Precision medicine is playing an increasingly crucial role in the treatment of prostate cancer. By tailoring treatments to the unique characteristics of patients and their tumors, this approach enables more targeted and personalized care, ultimately improving patient survival. In this article, we discuss the targeted therapies that have recently changed the management of this cancer.
Keywords
Male, Humans, Precision Medicine, Prostatic Neoplasms/diagnosis, Prostatic Neoplasms/genetics, Prostatic Neoplasms/therapy, Molecular Targeted Therapy, Palliative Care
Pubmed
Create date
24/05/2023 8:27
Last modification date
26/09/2023 5:58
Usage data
